Novel Pacing Mode Conserves Battery in Dual‐Chamber Leadless Pacemakers
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70224 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von James E Ip und 8 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Electric Power Supplies, Cardiac Pacing, Artificial, Arrhythmias, Cardiac. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
A dual‐chamber leadless pacemaker (LP) system has been developed, employing distinct atrial leadless pacemaker (ALP) and ventricular leadless pacemaker (VLP) devices that maintain atrioventricular synchrony via wireless implant‐to‐implant (i2i) communication with each beat. A new i2i communication‐free programming option was introduced to extend battery longevity and minimize unnecessary ventricular pacing by providing rate‐modulated atrial pacing with backup ventricular pacing when needed (AAI(R) + VVI). The clinical safety and longevity improvement have not been evaluated commercially.
Methods
Patients indicated for dual‐chamber pacing with new or existing dual‐chamber LP implants were enrolled in this prospective, nonblinded, interventional study. Device diagnostics and battery longevity were interrogated before and after 6 months (6 M) of AAI(R) + VVI programming, with any programming‐related complications or symptoms noted. Total ALP and VLP longevities were compared for DDD(R) at enrollment versus AAI(R) + VVI at 6 M.
Results
Dual‐chamber LP systems in 139 patients at six centers were evaluated (76 ± 11 years; 53% male; PR 210 ± 56 ms; 80% sinus node dysfunction, 16% AV block of any degree), including 16% new and 84% existing implants (enrolled 7.9 ± 7.5 months postimplant). The 84 patients completing the study ( n = 55 did not return) demonstrated a complication‐free rate of 100.0% and a symptom‐free rate of 97.6% ( n = 2; fatigue, dizziness, shortness of breath). In the 32 patients enrolled with existing implants already in DDD(R) mode who also completed the 6 M visit, AAI(R) + VVI extended the longevities of ALPs by 93% (5.8 ± 1.1 to 11.1 ± 2.7 years, p < 0.001) and VLPs by 61% (10.9 ± 2.1 to 16.9 ± 1.2 years, p < 0.001).
Conclusion
Clinical use of AAI(R) + VVI programming in dual‐chamber LPs over 6 M resulted in no complications, minimal symptoms, and significantly extended ALP and VLP battery longevities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA.
- Abbott, Sylmar, California, USA.
- Huntington Hospital, Pasadena, California, USA.
- St. Bernards Healthcare, Jonesboro, Arkansas, USA.
- Hoag Memorial Hospital, Newport Beach, California, USA.
- MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
ORCID-Profile: James E Ip, Mayer Rashtian
Zitieren
APA
Ip, J. E., Badie, N., Rashtian, M., Nair, D. G., Banker, R., Hadadi, C., Ryu, K., Ganz, L., & Doshi, R. N. (2026). Novel Pacing Mode Conserves Battery in Dual‐Chamber Leadless Pacemakers. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70224
Vancouver
Ip JE, Badie N, Rashtian M, Nair DG, Banker R, Hadadi C, et al. Novel Pacing Mode Conserves Battery in Dual‐Chamber Leadless Pacemakers. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70224
BibTeX
@article{Ip2026,
author = {Ip, James E and Badie, Nima and Rashtian, Mayer and Nair, Devi G and Banker, Rajesh and Hadadi, Cyrus and Ryu, Kyungmoo and Ganz, Leonard and Doshi, Rahul N},
title = {Novel Pacing Mode Conserves Battery in Dual‐Chamber Leadless Pacemakers},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70224}
}
EUVIMED